In agreement with this hypothesis, all of our 14 SF3B1mut samples were classified as early- (LP-CLL) and intermediate- (IP-CLL) programmed CLLs, and the role of IKAROS in B cell development has been highlighted in the early stages [43,76,77,78]. Here, IKZF1 is linked to B-cell chronic lymphocytic leukemia.